Dr. Xiao Wang is the CEO at InnoSpring Inc., the first US-China cross border technology incubator. Previously at InnoSpring she headed the business development and cross-border partnership team upon joining the company in 2012. In addition to her new role as CEO at InnoSpring, Dr. Wang is also the Project Manager at Entelos, a pharmaceutical consulting company. Here she advises global Pharmaceutical or Biotechnology companies in regards to drug development decisions, including target evaluation/ prioritization, translational medicine, biomarker analysis, and clinical trial design.。 ■

　　Dr. Wang has Co-Founded China America Innovation Network (CHAIN), a professional non-profit organization envisioned to help transform innovation into value through fostering entrepreneurship in 2011. She is an honored associate member of Tsinghua Entrepreneur and Executive Club (TEEC) and the president of Tsinghua Alumni Association of Northern California (THAA-NC).

　　Dr. Wang earned her Ph.D. in Biochemistry from Case Western Reserve University in Cleveland, Ohio and her B.S. in Biological Sciences from Tsinghua University in Beijing China.■